Published on 18 Mar 2024 on Zacks via Yahoo Finance
Here's Why Biogen Inc. (BIIB) Gained But Lagged the Market Today
In the latest market close, Biogen Inc. (BIIB) reached $219.40, with a +0.04% movement compared to the previous day. The stock's performance was behind the S&P 500's daily gain of 0.63%. Meanwhile, the Dow gained 0.2%, and the Nasdaq, a tech-heavy index, added 0.82%.
The company's shares have seen an increase of 0.1% over the last month, not keeping up with the Medical sector's gain of 0.91% and the S&P 500's gain of 1.76%.
Investors will be eagerly watching for the performance of Biogen Inc. in its upcoming earnings disclosure. The company's upcoming EPS is projected at $3.48, signifying a 2.35% increase compared to the same quarter of the previous year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.32 billion, down 5.66% from the year-ago period.